The individual comparisons of single biomarkers demonstrated that the IDH1 biomarker had significantly lower efficacy in discriminating patients with SCC or SCLC than the DNA methylation of the SHOX2 gene (p = 0.0106, Additional file 1: Table S3). Here, SHOX2 is linked to small cell lung carcinoma.